ACA vs MRK · P/E 57, rev $2.88B vs P/E 33, rev $65.01B
Arcosa Inc (ACA) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the ACA and MRK stock pages for the full models.
Not investment advice.